Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

Todd Neale

May 19, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Daily News

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

Michael O'Riordan

December 06, 2024

News Conference News HFSA 2024

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

L.A. McKeown

October 02, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Conference News HRS 2024

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

Michael O'Riordan

May 23, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Daily News

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

Yael L. Maxwell

May 08, 2024

News Conference News ACC 2024

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Caitlin E. Cox

April 15, 2024

News Conference News HFSA 2023

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

Shelley Wood

October 13, 2023

News Conference News ACC 2023

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Michael O'Riordan

March 07, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Conference News ACC 2022

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

Shelley Wood

April 03, 2022

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

Shelley Wood

April 01, 2022

News Daily News

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Michael O'Riordan

January 27, 2022

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

News Conference News ACC 2021

‘Enormous’ QoL Improvements With Mavacamten in HCM

Shelley Wood

May 15, 2021

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Shelley Wood

December 17, 2020

Advertisement

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

Top Heart Failure News of 2024

Sudden Cardiac Death in Athletes Is Rare, but Affects Black Population More

‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM

July 2024 Dispatch for the CV Team

Goal of Arrhythmia Care in Athletes is a Return to Play: HRS Consensus

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

New HCM Guidelines Focus on Cardiac Myosin Inhibitors and Exercise

IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM

Survey Offers Clues to Waning Appeal of Acute HF/Transplant Fellowships

Studies Support (Careful) Return to Sport for Athletes With Genetic Conditions

Top Heart Failure News of 2022

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report

Women Less Likely Than Men to Experience SCD During Sports

‘Enormous’ QoL Improvements With Mavacamten in HCM

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content